| abstract |
The present invention relates to the use of a compound of formula (I): wherein R1 represents a radionuclide, Ar represents an aromatic ring, m is an integer ranging from 2 to 4, R2 and R3 represent, independently of one another, other, a hydrogen atom, a (C1-C6) alkyl group, a (C1-C6) alkenyl group or an aryl group selected from phenyl, benzyl, imidazolyl, pyridyl, pyrimidinyl, pyrazinyl, indolyl, indazolyl, furyl and thienyl, as well as their pharmaceutically acceptable acid addition salts, for the preparation of a radiopharmaceutical composition for the diagnosis and / or treatment of melanoma. |